Feixiang, a history of more than 40 years after the enterprise, how many lofty dreams we need to step by step to pursue, how many huge blueprint waiting for a pen to describe you?

  • Elite Recruitment
  • Talent development
  • Career Opportunities
  • Common problem
  • Creating a talent to win the market leader, create organizational advantages, lead the value-oriented, mission and sense of responsibility of the talent team to support the realization of strategic objectives is to fly the continuous pursuit of talent.

  • Sustainable development
  • Management and system
  • Employees and society
  • Trustworthy partnership
  • Group adhere to the professional development of the road, the establishment of professional management system. We firmly believe that security is the basic conditions of all production and business activities, all the daily work must be "safety first."

  • The way of innovation
  • Technological innovation
  • Collaborative Innovation
  • There is no innovation on the lack of competitiveness, there is no innovation there is no value to enhance; in the "transformation and upgrading, innovation and development" under the guidance of long-term strategic objectives, flying up and down search, positive change, and always remain alive.

  • News Center
  • Company news
  • Industry news
  • Media reports
  • Here is our attitude, here is the link of the link, but the closest to our heartbeat.

  • Contact us
  • Contact us
  • Message
  • 聚焦领域 FOCUS AREAS
  • Chemical field
  • Agriculture
  • Education field
  • Health care
  • 联系我们 CONTACT

    Address:No.242, Changyang Street, Suzhou Industrial Park, Jiangsu Province

    Tel:0512-67995100

    E-mail:hr.fx@feixiangchem.com

    集团在健康医疗领域的投资 Your current location:Home > Focus on the field > 集团在健康医疗领域的投资

    雷火电竞app对健康的使命

    中国医疗卫生总费用和人均消费逐年在增长,并且人均卫生费用远低于发达国家,具有很大的发展空间。
    自2012年以来,集团一直在摸索如何进入医药领域,凭借多年的中间体高效工艺的开发与研究,规模中间体定制加工的产业化能力,通过注资美国威普特医药和澳洲翔实药业,初步建立了客户定制研发,晶体化学在医药配方中的研发,cGMP合成及小规模API生产的能力,为进军医药领域奠定了基础。


    集团投资了耶鲁大学的Jonathan Rothberg公司,由于其在基因测序方面的开创性工作荣获了国家技术和创新奖(National Medals of Technology and Innovation),被称为“生物科技领域的乔布斯”。

    同时,集团通过投资元生创投BIO VENTURE将领域拓展至医疗行业,目标未来在新药创制、智能医疗、高端器械、体外诊断等方面有一席之地。